Immuneering
IMRX
IMRX
52 hedge funds and large institutions have $119M invested in Immuneering in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $130M → $119M (-$11.1M)
Holders
52
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$606K | |
| 2 | +$200K | |
| 3 | +$178K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$83.9K |
| 5 |
State Street
Boston,
Massachusetts
|
+$82.4K |
Top Sellers
| 1 | -$2.76M | |
| 2 | -$1.03M | |
| 3 | -$818K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$633K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$629K |